KAZUHARU FURUTANI (@K_current) profile picture

カリフォルニア大学デービス校生理学助教授。医学博士(専門、薬理学)。大学で薬の効きかた研究しています。

Davis, CA
Joined February 2010
Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)Photo by KAZUHARU FURUTANI (@K_current)
KAZUHARU FURUTANI retweeted
Happy to share a new paper. Pore opening, not voltage sensor movement, underpins the voltage-dependence of facilitation by a hERG blocker molpharm.aspetjournals.org/c…
2
6
KAZUHARU FURUTANI retweeted
Excited to share the new paper co-authored with @VorobyovUCD, @clancyatheart, @sackyarov, @Kazu_Furutani entitled "Structural modeling of the hERG potassium channel and associated drug interactions" frontiersin.org/articles/10.…
6
13
NIHのスタディセクション(グラント審査)がおわった。15%しか通らないことの深刻さを感じる。三人のうち一人がoutstanding(10段階で1-2)でなくてexcellent (同3)といったらそれで大体そのグラントの終了が決定する。。。
13
4
KAZUHARU FURUTANI retweeted
Don Bers was featured in the Circ Res Leaders in Cardiovascular Science series. @MCIPUCD
LEADERS IN CARDIOVASCULAR SCIENCE: Donald Bers - A Heart for Puzzles ow.ly/hg2j30nUQPA #researchers
1
3
10
KAZUHARU FURUTANI retweeted
Two NIH funded POSTDOC positions available in the Navedo Lab at @ucdavis @UCDavisHealth. If you are interested in #ionchannels, #cellbiology, #signaltransduction, and #vascularbiology, please send your CV my way. Please RT!
Throwing a little science into the mix at the @JGenPhysiol #EdBoardMeeting 👩🏽‍🔬👨🏻‍🔬 JGP/SGP mixer to follow! #BPS2019
8
2
12
KAZUHARU FURUTANI retweeted
Got this. Thank you @JGenPhysiol #BPS19
2
7
Congratulations Gail Robertson (@hERGologie) on receiving the 2019 Cole Award. #bps2019 #mikejgp
9
1
30
KAZUHARU FURUTANI retweeted
In Baltimore for #BPS19
カリフォルニア大学機構(UC)はエルゼビア社(ELS)との学術雑誌購読契約を更新しないことになった。交渉決裂の理由はUC側は購読の一環としてUC所属研究者はELS出版の学術雑誌に無料でオープンアクセス論文公表できるよう要求したが、ELS側は別料金制度を譲らなかった。 universityofcalifornia.edu/p…
1
46
49
KAZUHARU FURUTANI retweeted
Take a read through of a new @NatRevDrugDisc paper from our faculty and collaborators on using #biologics to target #ionchannels! #sciencematters @UCDavisResearch
Heike Wulff, Palle Christophersen, Paul Colussi, K. George Chandy, and I published review on targeting ion channels with biologics I learned a lot from all co-authors! This review inspired new ideas for future research projects ;) nature.com/articles/s41573-0…
2
3
KAZUHARU FURUTANI retweeted
Heike Wulff, Palle Christophersen, Paul Colussi, K. George Chandy, and I published review on targeting ion channels with biologics I learned a lot from all co-authors! This review inspired new ideas for future research projects ;) nature.com/articles/s41573-0…
5
2
10
KAZUHARU FURUTANI retweeted
Great research from @Kazu_Furutani and @sackyarov labs!
Some hERG channel blockers are clinically safe, but others cause fatal cardiac arrhythmias. Furutani et al. show that safe blockers facilitate channel opening in ventricular myocytes and provide a repolarization reserve to suppress arrhythmias https://teapawt.net/t.co/2GUq9XeNYx
6
6
KAZUHARU FURUTANI retweeted
米国、生命医学•分子生物学分野の今年のテニュアトラック•アシスタントプロフェッサー職を得た50人のリスト。74%がCNSの筆頭著者。ポスドク所属は、ハーバード、スタンフォード、バークレー、UCSFなどトップ校がほぼ半数を占めるという、多様性の低さ。teapawt.net/JSheltzer/status/10928…
1
43
2
59
KAZUHARU FURUTANI retweeted
Check out amazing work by our biophysics faculty and collaborators!
Our @Kazu_Furutani just published a fascinating article in @JGenPhysiol proposing a mechanism that could explain why certain hERG blockers are less proarrhythmic than others–an important step towards efficiently developing clinically safe drugs! @UCDavisResearch @UCDavisHealth
2
3
KAZUHARU FURUTANI retweeted
Our @Kazu_Furutani just published a fascinating article in @JGenPhysiol proposing a mechanism that could explain why certain hERG blockers are less proarrhythmic than others–an important step towards efficiently developing clinically safe drugs! @UCDavisResearch @UCDavisHealth
Some hERG channel blockers are clinically safe, but others cause fatal cardiac arrhythmias. Furutani et al. show that safe blockers facilitate channel opening in ventricular myocytes and provide a repolarization reserve to suppress arrhythmias https://teapawt.net/t.co/2GUq9XeNYx
1
6
1
11
Some hERG channel blockers are clinically safe, but others cause fatal cardiac arrhythmias. Furutani et al. show that safe blockers facilitate channel opening in ventricular myocytes and provide a repolarization reserve to suppress arrhythmias https://teapawt.net/t.co/2GUq9XeNYx
3
1
Some hERG channel blockers are clinically safe, but others cause fatal cardiac arrhythmias. Furutani et al. show that safe blockers facilitate channel opening in ventricular myocytes and provide a repolarization reserve to suppress arrhythmias https://teapawt.net/t.co/2GUq9XeNYx